Associate Scientist, Histology
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Histotechnologist to join our Translational Medicine Department's Clinical Histology Core, supporting Immune Oncology clinical trial studies. In this role, you will use cutting-edge immunohistochemistry and in situ hybridization technologies to help our clinical colleagues understand how our immunotherapies treat and potentially cure patients across a wide range of cancers, working in a cross-functional environment with close interaction with Research and Translational Medicine colleagues.
Job description
Discover your role:
- Prepare serial sections from biopsy samples, where section quality directly influences downstream staining and analysis
- Cut control tissue, such as tonsil, for IHC and in situ hybridization studies
- Perform H&E staining on automated instruments
- Operate automated staining platforms, maintaining instruments and preparing bulk solutions
- Receive clinical samples from outside collaborators, recording sample details and processing tissue
- Scan slides on an automated slide scanner, QC images, and transfer files to the server
- Work independently on the planning and execution of staining runs
- Bring a willingness to learn new techniques and expand your role within the group
Requirements
- BS with 2+ years of relevant experience
- Proven track record working with human FFPE tissue
- Experience accurately and reliably cutting serial sections, including on limited amounts of tissue
- Experience sectioning biopsy samples
- Strong organizational, computer, and time management skills, with the ability to work as part of a team and meet tight deadlines
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension Or Retirement Benefits
- 401(k) Company Match
- Health And Wellness Programs
- Fitness Centers
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.